Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.Amgen: A Biotech BellwetherIn biotechnology, corporate success is a function of approved drugs, pipeline activity and positive cash flow. By those standards, one of the most successful firms in the industry is a 27-year-old Thousand Oaks, California outfit that was among the first developers of blockbu[...]
Read More...
[Source: The Money Blogs]
No comments:
Post a Comment